Assessing Antibody ADCC Activity by Affinity HPLC
The Application Notebook
Antibody-dependent cell-mediated cytotoxicity (ADCC) is a crucial mechanism of action (MoA) of anti-tumour therapeutic antibodies and FcγIIIa receptor plays a key role in this process by interacting with the N-glycans of IgG Fc regions. Hence, affinity chromatography on Fc receptor ligands can deliver valuable information about expected ADCC activity and mAb glycoform distribution.
Antibody-dependent cell-mediated cytotoxicity (ADCC) is a crucial mechanism of action (MoA) of anti-tumour therapeutic antibodies and FcγIIIa receptor plays a key role in this process by interacting with the N-glycans of IgG Fc regions. Hence, affinity chromatography on Fc receptor ligands can deliver valuable information about expected ADCC activity and mAb glycoform distribution.
A new HPLC column, TSKgel FcR-IIIA-NPR, is based on a recombinant FcγIIIa receptor ligand and allows fast assessment of biologic activity of monoclonal antibodies (mAbs). As Fc-glycans of antibodies are known to play an important role in Fc-mediated interactions, the separation pattern of mAbs on TSKgel FcR-IIIAâNPR can be correlated to FC-glycans as well (1). Terminal galactose residues increase affinity to FcγRIIIa while core fucose residues reduce it. This correlates with the known influence of galactose and fucose on antibody-dependent cell-mediated cytotoxicity (ADCC) activity. Accordingly, early eluting peaks of TSKgel FcR-IIIA-NPR represent glycoforms with low ADCC activity, while late eluting peaks represent glycoforms with high ADCC activity (Figure 1).
Separation of mAb Glycoforms
Figure 2 demonstrates the specificity of the recombinant FcγRIIIA ligand for N-glycans of the Fc domain of mAbs. Adalimumab analyzed with TSKgel FcR-IIIA-NPR shows a typical pattern of three peaks, corresponding with the molecule’s glycan heterogeneity. Treatment of adalimumab with PNGase F de-glycosylates the sample. De-glycosylated adalimumab does not bind to TSKgel FcRâIIIA-NPR; the N-glycan related peaks are absent.
HPLC Conditions
Column: TSKgel FcR-IIIA-NPR (4.6 mm × 7.5 cm L, 5-µm)
Mobile Phase:
A: 50 mmol/L sodium citrate, pH 6.5;
B: 50 mmol/L sodium citrate, pH 4.5
Flow Rate: 1 mL/min
Temp.: 25 °C
Detection: UV @ 280 nm
Sample: 50 µL of adalimumab or PNGase F treated adalimumab (1 µg/µL)
Conclusion
A rapid 30-min separation on TSKgel FcR-IIIA-NPR allows the analysis of large numbers of mAb samples to gain valuable first information on the distribution of glycoforms and expected ADCC activity. This fast and efficient method can be applied to purified samples and supernatant alike and can be used in many phases of development and production such as cell line screening in early R&D, biosimilar or originator comparison, upstream development and optimization, monitoring of glycoengineering, or lot-to-lot comparison in QC.
Reference
- M. Kiyoshi et al., Sci. Rep.8, 3955 (2018) doi:10:1038/s41598-018-22199-8
- TSKgel is a registered trademark of Tosoh Corporation
Tosoh Bioscience GmbH
Im Leuschnerpark 4 64347 Griesheim, Darmstadt, Germany
Tel: +49 6155 7043700 Fax: +49 6155 8357900
E-mail: info.tbg@tosoh.com
Website: www.tosohbioscience.de
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
